Delusions and Hallucinations in Neuromyelitis Optica Spectrum Disorder with AQP4-IgG: A Case-Based Systematic Review

被引：0
|
作者：
Delgado-Garcia, Guillermo [1 ]
Alberto Sanchez-Garza, Jose [1 ]
Ramirez-Bermudez, Jesus [2 ]
Rivas-Alonso, Veronica [1 ]
Flores-Rivera, Jose [1 ]
Corona-Vazquez, Teresa [1 ]
机构：
[1] Natl Inst Neurol & Neurosurg, Mexico City, DF, Mexico
[2] Natl Inst Hlth, Coordinating Commiss, Mexico City, DF, Mexico
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P220
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [21] Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorder
    Maillart, Elisabeth
    Renaldo, Florence
    Papeix, Caroline
    Deiva, Kumaran
    Bonheur, Julie
    Kwon, Teresa
    Boespflug-Tanguy, Odile
    Germanaud, David
    Marignier, Romain
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (03):
  • [22] AQP4-IgG-positive neuromyelitis optica spectrum disorder and temporally detected neoplasms: case report and systematic review
    Apiraksattayakul, Natnasak
    Songwisit, Sakdipat
    Owattanapanich, Weeraphat
    Tisavipat, Nanthaya
    Siritho, Sasitorn
    Prayoonwiwat, Naraporn
    Rattanathamsakul, Natthapon
    Jitprapaikulsan, Jiraporn
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
  • [23] Neuromyelitis Optica Spectrum Disorders (NMOSD) and AQP4-IgG in an Australian Pediatric Demyelination Cohort
    Dahan, Ariel
    Dale, Russell
    Brilot, Fabienne
    Kornberg, Andrew
    Yiu, Eppie
    NEUROLOGY, 2016, 86
  • [24] Neuromyelitis Optica Spectrum Disorders (NMOSD) and AQP4-IgG in an Australian Pediatric Demyelination Cohort
    Dahan, Ariel
    Dale, Russell
    Brilot, Fabienne
    Kornberg, Andrew
    Yiu, Eppie
    NEUROLOGY, 2016, 86
  • [25] Aqp4-igg seronegative patient outcomes in the n-momentum trial of inebilizumab in neuromyelitis optica spectrum disorder
    Pittock, S.
    Paul, F.
    Marignier, R.
    Kim, H. J.
    Bennett, J.
    Weinshenker, B.
    Wingerchuk, D.
    Green, A.
    Fujihara, K.
    Cutter, G.
    Aktas, O.
    Hartung, H. P.
    Drappa, J.
    Ratchford, J.
    She, D.
    Cimbora, D.
    Katz, E.
    Cree, B.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 208 - 209
  • [26] Longitudinal evaluation of clinical characteristics of Chinese neuromyelitis optica spectrum disorder patients with different AQP4-IgG serostatus
    Zhang, Xiang
    Liu, Xiaoni
    Yu, Hai
    Deng, Bo
    Zhang, Yue
    Chen, Xiangjun
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 62
  • [27] Inebilizumab treatment in a patient with co-occurring AQP4-IgG positive neuromyelitis optica spectrum disorder and myasthenia gravis: a case report and literature review
    Song, Xiaoqian
    Chen, Jingjiao
    Jin, Chenyang
    Peng, Yilong
    Sun, Yuewen
    Zheng, Xueping
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [28] Neuromyelitis optica spectrum disorder (NMOSD) seropositive for AQP4-IGG more than 3 years before NMOSD onset
    Kitami, Y.
    Mori, T.
    Hayakawa, I.
    Koide, A.
    Ito, A.
    Suzuki, H.
    Tomita, S.
    Warabi, Y.
    Takahashi, T.
    Miyama, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 1146 - 1146
  • [29] AQP4-IgG detection and the clinical analysis of Chinese patients with neuromyelitis optica
    Zhang, Xiang
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 660 - 661
  • [30] Serum AQP4-IgG level is associated with the phenotype of the first attack in neuromyelitis optica spectrum disorders
    Akaishi, Tetsuya
    Takahashi, Toshiyuki
    Himori, Noriko
    Fujihara, Kazuo
    Misu, Tatsuro
    Abe, Michiaki
    Ishii, Tadashi
    Nakazawa, Toni
    Aoki, Masashi
    Nakashima, Ichiro
    JOURNAL OF NEUROIMMUNOLOGY, 2020, 340
12345